Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2026)

Elanco Animal Health has disclosed Share-based Compensation across 10 years of filings, most recently posting $7.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 65.0% year-over-year to $7.0 million; the TTM figure through Jun 2026 stood at $74.0 million (up 13.85% YoY), while the FY2025 annual figure was $68.0 million, up 23.64% from the prior year.
• Share-based Compensation came in at $7.0 million for Q2 2026 at Elanco Animal Health, down from $34.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $65.0 million in Q4 2022 to a low of $7.0 million in Q2 2026.
• Average Share-based Compensation over 5 years is $17.7 million, with a median of $15.0 million recorded in 2023.
• Year-over-year, Share-based Compensation soared 261.11% in 2022 and plunged 76.92% in 2023.
• Over 5 years, Share-based Compensation stood at $65.0 million in 2022, then plunged by 76.92% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then rose by 6.67% to $16.0 million in 2025, then sank by 56.25% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $7.0 million in Q2 2026, $34.0 million in Q1 2026, and $16.0 million in Q4 2025.